Crowdonomics
20/20 GeneSystems

Reg CF · Convertible Note · Oct 2025

ClosedReached targetReg CFConvertible Note
via PicMii · last checked Sep 3, 2026View campaign
Raised
$748.9K / $350K max
100% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$1.4M
−$6.4M
FY2023
$1.8M
−$5.6M
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$1,424,304
$1,752,343
Cost of goods sold
$1,315,166
$1,392,032
Gross margin
8%
21%
Net income
-$6,391,309
-$5,551,667
Taxes paid
$0
$0
Balance sheet
Cash
$4,089,461
$1,784,009
Accounts receivable
$68,834
$135,272
Total assets
$6,367,828
$3,584,408
Short-term debt
$0
$1,011,623
Long-term debt
$229,164
$1,068,713
Total liabilities
$2,080,336
$2,078,926
Other
Headcount
21
20

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Dec 12, 2025
    • Deadline Dec 12, 2025 → Dec 13, 2025

    “Extending the offering to December 13th, 2025.”

    Form C/A on EDGAR ↗
  2. Nov 26, 2025
    • Deadline Dec 5, 2025 → Dec 12, 2025

    “Extending the offering to December 12th, 2025.”

    Form C/A on EDGAR ↗
  3. Nov 4, 2025
    • Deadline Nov 30, 2025 → Dec 5, 2025

    “Extending the offering to December 5th, 2025.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$10,000
Max$350,000
Min investment—
OpenedOct 30, 2025
DeadlineDec 13, 2025
ClosedDec 13, 2025
Days active44

Links & provenance

Source: SEC EDGAR
0001139685-25-000010
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.